[The experience of anti-TNF-alpha registries and observatories].
Sibilia
Jean
J
Service de Rhumatologie, Hôpital Hautepierre, 1, avenue Molière, 67092 Strasbourg, France.
Solignac
M
M
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration; D001424:Bacterial Infections / Q000453:epidemiology / Q000209:etiology; D001691:Biological Therapy / Q000706:statistics & numerical data; D016208:Databases, Factual; D004198:Disease Susceptibility; D005602:France; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007253:Information Centers / Q000458:organization & administration; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology; D009894:Opportunistic Infections / Q000453:epidemiology / Q000209:etiology; D011565:Psoriasis / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D012306:Risk; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha